Background
==========

Acute respiratory tract infections (ARI) are a leading cause of morbidity and mortality in children worldwide \[[@B1]\] accounting for about 30% of all childhood deaths in developing world \[[@B2]\]. Viruses account for 50--90% of acute lower respiratory tract infections (ALRI) in young children \[[@B3]\] with respiratory syncytial virus (RSV), parainfluenza viruses (PIV), influenza viruses A and B and human metapneumoviruses (hMPV) being most commonly identified \[[@B4]-[@B6]\].

Respiratory infections caused by above said viruses usually present with clinical features that are nearly indistinguishable \[[@B7]\]. The increased sensitivity of polymerase chain reaction (PCR) over conventional methods for the diagnosis of respiratory viral infections has been established previously \[[@B8]\]. However, organism-specific RT-PCR assays which require separate amplification of each virus under investigation are resource intensive, time consuming and labor intensive \[[@B9]\].

Multiplex PCRs (mPCR) detect multiple organisms in a single assay and are available either as commercial assays \[[@B9]-[@B12]\] or in-house assays \[[@B4],[@B5],[@B13]-[@B17]\]. Majority of the in-house mPCR assays have not included recently discovered respiratory pathogens and require validation of results by post PCR hybridization or semi/nested PCR which make the assay cost ineffective and increases chances of cross contamination. Commercially available mPCR assays are expensive and require dedicated instrumentation \[[@B18]\].

We developed a simplified and economical multiplex PCR assay without any post PCR hybridization/nested PCR steps for the detection of seven major respiratory viruses.

(This material was presented in part at the 7^th^Asia Pacific Congress of Medical Virology held at New Delhi, India in November 2006 and Options for the Control of Influenza VI held at Toronto, Canada in June 2007.)

Results
=======

The primer set designed for PIV1 failed to amplify PIV1 RNA after repeated attempts. The primer set published by Osiowy in 1998 \[[@B17]\] was found to amplify PIV1 N gene successfully.

Standardization of cDNA synthesis
---------------------------------

Ten Units of the AMV-RT enzyme, 500 ng of random hexamer primer (PdN~6~), 500 μM dNTP concentration and 8 U of RNAsin were found to be optimal for 25 μl cDNA synthesis.

Standardization of multiplex PCR
--------------------------------

All seven sets of primers when combined led to mispairing and nonspecific amplification. After trying different combinations, it was observed that RSV, Influenza A and B viruses in one set and PIV1--3 and hMPV in another set gave specific amplification for each virus (Figure [1](#F1){ref-type="fig"}).

![**Standardization of two tube multiplex PCR for RSV, Influenza A&B viruses in first tube and PIV1--3 and hMPV in the second tube**. Lane 1: Marker Ø X174 (*Hae III*digested). Lane 2: Amplicon forRSV showing band of 683 bp, Influenza A of 105 bp, Influenza B of 503 bp. Lane 3: Marker 100 bp ladder. Lane 4: Amplicon for PIV1 showing band of 84 bp, PIV2 of 197 bp, PIV3 of 266 bp, and hMPV of 440 bp.](1743-422X-6-89-1){#F1}

Optimized reagent and PCR cycling conditions for first and second tube multiplex PCR
------------------------------------------------------------------------------------

The optimized reagent concentrations for each tube were 25 pM of each primer, 400 μM of dNTPs, 2 mM MgCl~2~and 6 U of Taq polymerase enzyme. The optimized cycling conditions for both tubes were: 94°C for 3 min followed by 35 cycles of 94°C for 1 min, 55°C for 1 min (53°C for 1 min for second tube) and 72°C for 1 min. Final extension was done at 72°C for 10 min for first tube and 7 min for second set.

Sensitivity and specificity of multiplex PCR
--------------------------------------------

The sensitivity of detection by two tube multiplex PCR was 0.1TCID~50~for RSV, Influenza A and 1TCID~50~for hMPV, PIV1, PIV2, PIV3 and Influenza B. There were no non-specific amplification products against RNA from heterologous sources.

Detection of seven respiratory viruses in clinical samples
----------------------------------------------------------

### Study group

Three hundred and one children from OPD and ward with ALRI were enrolled in the study. Of the 166 children seen in the outpatient department, 137 (82.5%) had ALRI, 29 (17.5%) had severe ALRI and none had very severe ALRI (as per WHO classification). Of the 135 children admitted to pediatric ward, 35 (26%) had ALRI, 92 (68%) had severe ALRI and 8 (6%) had very severe ALRI (Table [1](#T1){ref-type="table"}). More number of children with ALRI were seen in the OPD as compared to pediatric ward (p \< 0.05, Pearson Chi square test). However, for severe ALRI, more children were admitted than seen in OPD (p \< 0.05, Pearson Chi square test).

###### 

Distribution of children with ALRI/Severe ALRI/very severe ALRI from OPD or pediatric ward

  Site             Clinical presentation   Total                  
  ---------------- ----------------------- ------------ --------- -----
  OPD              137 (79.6)^a^           29 (24)^b^   0         166
  Pediatric Ward   35 (20.4)^a^            92 (76)^b^   8 (100)   135
  Total            172                     121          8         301

^a,\ b^p value ≤ 0.05, Pearson chi square test

All the 301 children enrolled in the study were in the age range of 1--72 months with the median age of 11 months. The mean of their age was 15.6 ± 14 months. Among them 217 were males and 84 were females (Male: Female ratio = 2.6:1). It was observed that there was no significant difference between the age range of children with ALRI or severe ALRI from OPD or Ward (p \> 0.05).

Detection of seven respiratory viruses in children with ALRI
------------------------------------------------------------

Of the 301, 106 children (35.2%) had viral infections and were positive for 130 respiratory viruses. Of these 106 children with ALRI, 64 presented to the OPD and 42 were admitted to the ward. Of the 64 children who presented to OPD, 52 had ALRI and 12 had severe ALRI. Of the 42 children who were admitted, 8 had ALRI, 31 had severe ALRI and 3 had very severe ALRI (Table [2](#T2){ref-type="table"}).

###### 

Distribution of children with ALRI/Severe ALRI/very severe ALRI from OPD or pediatric ward positive for different respiratory viruses

  Site                   Clinical presentation   Total                      
  ---------------------- ----------------------- -------------- ----------- -----
  OPD                    52/60 (81.3)            12/43 (27.9)   0           64
  Pediatric Ward         8/60 (18.7)             31/43 (70.1)   3/3 (100)   42
  Total virus positive   60                      43             3           106

In 106 children in whom respiratory viruses were detected, the age range was 1--72 months with a median of 12 months and the mean age was 15.8 ± 13.8 months. In the PCR negative group, the age range was 1--61 months with a median of 10 months and the mean age was 15.5 ± 14.1 months. This difference was not statistically significant between the two groups. There was no significant difference in the male female ratio between the two groups.

RSV was detected in 61, PIV3 in 22, PIV2 in 17, hMPV in 11, PIV1 in 10 and Influenza A in 9 children respectively (Table [3](#T3){ref-type="table"}). Figure [2](#F2){ref-type="fig"} shows detection of single and mixed infections in some samples on which two tube multiplex PCR was applied. Of these, 86 were single virus infections and mixed infections were seen in 20 children (18.8% of the 106 children). Nested PCR for RSV identified the presence of RSV B in all 61 samples. Of the single infections, RSV comprised 50, hMPV 9, Influenza A and PIV3 8 each, PIV2 6 and PIV1 5.

###### 

Virus identifications in children with ALRI detected positive for viral infections by multiplex PCR

  **Viruses detected by mPCR**   **Number of specimens**
  ------------------------------ -------------------------
  RSV                            50
  Influenza A                    8
  PIV1                           5
  PIV2                           6
  PIV3                           8
  hMPV                           9
  PIV2+PIV3                      6
  RSV+PIV2+PIV3                  3
  RSV+PIV3                       3
  RSV+PIV1                       3
  RSV+PIV2                       1
  PIV3+INFA                      1
  PIV1+PIV2+PIV3                 1
  RSV+hMPV                       1
  hMPV+PIV1                      1
                                 
  TOTAL                          106

![**Application of two tube multiplex PCR on clinical samples**. **Panel A**. Lane 1: 100 bp DNA ladder. Lane 2: Clinical sample showing amplicon of 105 bp for FLU A. Lane 3: Clinical sample showing amplicon of 683 bp for RSV. Lane 4: Clinical sample showing amplicon of 440 bp for hMPV. Lane 5: Clinical sample showing amplicon of 266 bp for PIV3. Lane 3: Negative clinical sample. **Panel B**. Lane 1: 100 bp DNA adder. Lane 2: Clinical sample showing mixed infection of PIV1 (84 bp), PIV2 (197 bp) and PIV3 (266 bp).](1743-422X-6-89-2){#F2}

It was seen that the percentage of virus detections by multiplex PCR were higher in the children with ALRI seen as outpatients (37.2%) as compared to those admitted to the ward (22.8%). Similarly, in the children with severe ALRI, seen as outpatients were higher percentage was positive for viruses (45%) as compared to those admitted to the ward (33.7%). It was observed that of all the mixed infections, 5.8% of them had ALRI whereas 7.8% of them had severe and very severe ALRI. Although severe ALRI was seen in higher number of children with mixed infections as compared to those with ALRI with mixed infections, the difference between the groups was not statistically significant.

Co-relation between multiplex PCR and tissue culture
----------------------------------------------------

The \"gold standard\" isolation in tissue culture by CEC-IIF detected 79 (61%) viruses as compared to 130 by multiplex PCR. CEC-IIF could not detect the presence of viruses in samples with mixed infections (data not shown). The sensitivity, specificity and likelihood ratio between the two assays is shown in Table [4](#T4){ref-type="table"}.

###### 

Validity of multiplex PCR in comparison to CEC-IIF for the detection of respiratory viruses in children with ALRI

  **Results (RT-PCR/CEC-IIA)**      RSV    INF A   PIV1   PIV2   PIV3   hMPV
  --------------------------------- ------ ------- ------ ------ ------ ------
  **+/+**                           27     8       5      10     18     11
  **+/-**                           34     1       5      7      4      0
  **-/-**                           274    293     296    291    283    290
  **-/+**                           0      0       0      0      0      0
  **Total samples**                 301    301     301    301    301    301
  **Sensitivity (%)**               100    100     100    100    100    100
  **Specificity (%)**               88.9   99.6    98.3   97.6   98.6   100
  **Likelihood ratio (positive)**   9      250     59     42     71     \-

Temporal distribution of respiratory viruses
--------------------------------------------

The number of RSV infections increased during late fall and peaked between October and January during the first year of the study. During the next year of the study, the distribution of RSV was scattered. PIVs were detected during the first year of the study, influenza A in winter months and hMPV in spring season (Figure [3](#F3){ref-type="fig"}).

![**Monthly distribution of ALRI causing viruses detected during the study**.](1743-422X-6-89-3){#F3}

Cost effectiveness of the multiplex PCR assay
---------------------------------------------

The cost per sample detected by two tube multiplex PCR assay was USD16 (RNA extraction USD6, cDNA synthesis USD2.5 and two tube multiplex PCR USD4.5, equipment and personnel cost USD3) as compared to the cost per sample by culture being USD24 (Sample collection USD2, sample processing USD2, inoculation of sample on to 3 different cell lines USD8, indirect immunofluorescence USD3, visualization under fluorescent microscope USD3, equipment and personnel cost USD6).

Clinical symptoms
-----------------

The clinical features, demographics and risk factors of children with viral infections and RSV alone were compared with the virus negative group (Table [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}). It was observed that significantly higher number of children below 12 months of age had RSV infection. Children presenting with preceding bronchiolitis were significantly associated with total viral infections and RSV infection (p \< 0.05). Runny nose was significantly present in children with RSV infection (p \< 0.05). Among risk factors, ARI in family was found to be associated with virus positive children (p \< 0.005).

###### 

Children with ALRI positive and negative for respiratory viruses by multiplex PCR

  **Variables**             **Virus positive (n = 106)**   **Virus negative (n = 195)**   **p value**   **OR (95% CI)**
  ------------------------- ------------------------------ ------------------------------ ------------- --------------------
  Median age (Mo)           12 (1--72)                     10 (1--61)                     0.36          \-
  Sex M:F                   74:32 (2.3:1)                  143:52 (2.8:1)                 0.51          1.2 (0.68, 2.1)
  **Clinical symptoms**                                                                                 
  Cough                     102                            183                            0.43          3.1 (0.99, 1.25)
  Difficulty in breathing   70                             113                            0.17          1.4 (0.84, 2.4)
  Runny nose                50                             70                             0.05          1.6 (0.96, 2.6)
  Sore throat               5                              2                              0.10          4.8 (0.76, 51.2)
  Fever                     88                             159                            0.74          1.1 (0.57, 2.2)
  Hoarseness                6                              6                              0.27          1.9 (0.49, 7.3)
  Asthma                    7                              7                              0.23          1.9 (0.55, 6.5)
  Grunting                  3                              5                              0.99          1.1 (0.17--5.8)
  Nasal flaring             13                             18                             0.40          1.4 (0.59--3.1)
  Stridor                   3                              5                              0.99          1.1 (0.17--5.8)
  Chest indrawing           40                             80                             0.57          0.87 (0.52--1.5)
  Cyanosis                  5                              7                              0.63          1.3 (0.32, 5.0)
  Recurrent pneumonia       7                              15                             0.03          4.5 (1.1, 27.6)
  Pneumonia                 84                             151                            0.71          1.1 (0.60, 2.1)
  **Bronchiolitis**         **52**                         **42**                         **0.001**     **3.5 (2.0, 6.0)**
  **Risk factors**                                                                                      
  **ARI in family**         **51**                         **62**                         **0.005**     **1.9 (1.2, 3.3)**
  Prematurity               14                             13                             0.05          0.87 (0.41, 1.8)
  Smokers in family         36                             67                             0.94          0.98 (0.58, 1.7)
  Co-morbidity              19                             66                             0.003         0.43 (0.23, 0.78)

###### 

Children with ALRI positive and negative for RSV by multiplex PCR

  **Variables**             **RSV positive (n = 50)\***   **Virus negative (n = 195)**   **p value**   **OR (95% CI)**
  ------------------------- ----------------------------- ------------------------------ ------------- ----------------------
  Median age (Mo)           10.5 (2--48)                  10 (1--61)                     0.60          \-
  **Less than 12 months**   **38**                        **115**                        **0.027**     **2.2 (1.1, 4.5)**
  Sex M:F                   35:15 (2.3:1)                 143:52 (2.8:1)                 0.63          1.2 (0.55, 2.4)
  **Symptoms**                                                                                         
  Cough                     49                            183                            0.47          3.2 (.45, 140.1)
  Difficulty in breathing   30                            113                            0.79          1.1 (0.55, 2.2)
  **Runny nose**            **32**                        **70**                         **0.001**     **3.2 (1.6, 6.4)**
  Sore throat               0                             2                              0.99          \-
  Fever                     44                            159                            0.27          1.7 (0.64, 5.1)
  Hoarseness                4                             6                              0.12          2.7 (0.54, 12.0)
  Asthma                    4                             7                              0.24          2.3 (0.49, 9.6)
  Grunting                  2                             5                              0.63          1.6 (0.15, 10.0)
  Nasal flaring             5                             18                             0.86          1.1 (0.30, 3.3)
  Stridor                   2                             5                              0.63          1.6 (0.15, 10.0)
  Chest indrawing           19                            80                             0.69          0.88 (0.44, 1.7)
  Cyanosis                  0                             7                              0.35          \-
  Recurrent pneumonia       3                             15                             0.99          4.1 (0.53, 31.2)
  Pneumonia                 38                            151                            0.82          0.92 (0.43, 2.1)
  **Bronchiolitis**         **41**                        **42**                         **0.001**     **16.6 (7.1, 41.4)**
  **Risk factors**                                                                                     
  ARI in family             23                            62                             0.06          1.8 (0.92, 3.6)
  Prematurity               6                             13                             0.20          1.9 (0.56, 5.7)
  Smokers in family         20                            67                             0.45          1.3 (0.63, 2.5)
  Co-morbidity              5                             66                             0.001         0.22 (0.06, 0.59)

\* episodes of co-infection with other viruses were excluded

Discussion
==========

The development of multiplex PCR for the detection of respiratory viruses as a rapid, sensitive and time saving technique has not gained priority in India even though \~0.5 million children die each year in this country due to ALRI each year, accounting for one fourth of the 1.9 million global ALRI deaths \[[@B19]-[@B21]\]. Among all the major ALRI causing viruses namely RSV, PIVs and influenza viruses A and B, the presence of RSV has been documented to be the most commonly identified pathogen followed by PIV3 \[[@B22]\]. In the present study, we standardized and evaluated an economical two-tube multiplex PCR assay devoid of any further confirmatory steps. The present assay reagents costs were mere USD16/reaction in contrast to USD90/reaction \[[@B18]\] reported for a commercial assay. The sensitivity of our multiplex PCR assay was similar or better than previously described mPCR assays for these viruses \[[@B5],[@B16],[@B17],[@B23],[@B24]\]. We did not make direct comparisons of the performance of the different assays in our laboratory.

In the present study we could culture majority of the viruses detected by mPCR with the exception of RSV which is known to be highly thermolabile \[[@B25]\]. The detection rate of viruses was similar to detection rate reported earlier \[[@B16],[@B17],[@B24],[@B26]\]. It was observed that a higher proportion of virus positive children presented to the OPD than the ward, similar to a study from Taiwan \[[@B26]\] and could be due to the fact that the patients present earlier after onset of symptoms to the OPD as compared to getting admitted to the Ward. However, this could also be because severe disease is more likely to be admitted to the hospital and caused by bacteria than virus \[[@B27]\]. A higher proportion of males were found to have infection with respiratory viruses as compared to females as reported earlier \[[@B28],[@B29]\].

RSV was most commonly identified viral pathogen similar to previously described viral identifications by mPCR \[[@B16],[@B17],[@B28],[@B29]\]. PIVs were the second most frequently identified pathogens \[[@B29]\] followed by hMPV \[[@B22],[@B28]-[@B30]\] and Influenza A virus infections \[[@B16],[@B24],[@B28]\].

The detection rate of co-infections was similar to previously reported multiplex PCR studies \[[@B5],[@B14]-[@B17],[@B28],[@B29]\]. It was observed that higher percentage of children with mixed infections had severe and very severe ALRI as compared to ALRI. Previous studies have shown that co-infection with different respiratory viruses might lead to a more severe disease \[[@B31]\] or multiple viruses have been detected from patients with severe disease \[[@B32]\].

ALRI caused by RSV was more common in younger children as reported previously \[[@B28]\]. RSV and hMPV were associated with bronchiolitis \[[@B28],[@B29],[@B33],[@B34]\]. PIVs and Influenza viruses were associated with pneumonia similar to previous findings \[[@B28],[@B29]\]. However, the number of all the viral detections except RSV was too few to comment on the association of the virus with bronchiolitis or pneumonia.

In the present study, RSV was detected during the fall season similar to previously described studies from our laboratory \[[@B35]-[@B37]\]. The rest of the virus identifications were few and their seasonality cannot be commented upon.

Conclusion
==========

In conclusion, we report a simplified multiplex PCR for the detection of seven respiratory viruses in samples from children with ALRI. This assay was found to be more sensitive, less time consuming and economical than virus isolation. Multiplex PCR format allowed the detection of co-infections which cannot be done using monoplex PCR or culture as shown in the present study.

Methods
=======

Patient Specimens
-----------------

Between April 2005 and March 2007, nasopharyngeal aspirates (NPAs) were collected from children ≤ 5 years of age with ALRI, severe ALRI and very severe ALRI as per WHO criteria \[[@B38]\] and are shown in Table [7](#T7){ref-type="table"}.

###### 

Classification of ARLI, severe ALRI and very severe ALRI in children from 2 months to 5 years of age

  **Signs**                                                   **Classify as**
  ----------------------------------------------------------- ------------------
  Fast breathing as per following criteria according to age   ALRI
  \-- age less than 2 months: ≥ 60/minute                     
  \-- age 2--11 months: ≥ 50/minute                           
  \-- age 1--5 years: ≥ 40/minute.                            
                                                              
  Above symptoms with:                                        Severe ALRI
  \-- Chest indrawing                                         
  \-- Stridor                                                 
  \-- Nasal flaring                                           
  \-- Grunting                                                
  Symptoms of severe pneumonia with:                          Very severe ALRI
  \-- central cyanosis                                        
  \-- inability to breastfeed or drink                        
  \-- vomiting everything                                     
  \-- convulsions, lethargy or unconsciousness                
  \-- severe respiratory distress.                            

Adapted from POCKET BOOK of Hospital Care for Children Guidelines for the Management of Common Illnesses with limited resources

ISBN 92 4 154670 0 (NLM classification: WS 29)

The children were either seen at the Outpatient Department (OPD) or admitted to the Pediatric Ward of All India Institute of Medical Sciences (AIIMS) Hospital, New Delhi, India. The demographic profile of child, clinical symptoms and risk factors were recorded in a predesigned proforma. NPAs were collected and processed as described earlier \[[@B39]\].

Standard strains of viruses
---------------------------

Standard strains of 9 viruses namely human respiratory syncytial virus (A2 and 18537), PIV1 (Washington/1964), PIV2 (Greer), PIV3 (D10025), influenza A {H1N1 (A/New Caledonia/20/99) and H3N2 (A/Panama/2007/99)} and B viruses and human metapneumovirus hMPV (Can 97--83) were cultured in Hep-2, MDCK and LLCMK-2 cells as described elsewhere \[[@B39]-[@B41]\].

RNA extraction
--------------

RNA was extracted from standard strain of the virus by guanidinium thiocyanate method \[[@B42]\] and 500 μl of NPA using RNeasy kit (Qiagen, GmBH, Germany) described previously \[[@B39]\].

cDNA synthesis
--------------

cDNA synthesis was optimized using 5--20 units of AMV-RT enzyme, 500 ng -1000 ng random hexamer primer (PdN~6~), 0.1--2 mM dNTPs, 4--8 units of RNAsin (all reagents from Promega, Madison, WI, USA) and 5--10 μl of RNA in a 25 μl reaction volume.

Primer Designing
----------------

For RSV, PIVs and hMPV primers were designed from nucleocapsid region and for Influenza (A and B) from the matrix region using sequences available in GenBank, using program OLIGO (Molecular Biology Insights, Cascade, CO, USA, <http://oligo.net>) and oligonucleotide *T*m calculator (<http://idtdna.com>). The sequence of all the seven sets of primers and nested primers for RSV group A and B are shown in Table [8](#T8){ref-type="table"}.

###### 

Sequences of oligonucleotides used for detection of viruses in the study

  **Target gene**               **Primer**   **Position (nucleotide)**                                                                                      **Sequence (5\' to 3\')**           **Amplicon size**
  ----------------------------- ------------ -------------------------------------------------------------------------------------------------------------- ----------------------------------- -------------------
  RSV N gene                    RSVNF        52--71 bp relative to RSV A (U39961) and RSV B (AF013254)                                                      CTGTCATCCAGCAAATACAC                683 bp
                                RSVNR        711--734 bp relative to RSV A (U39961) and RSV B (AF013254)                                                    ACCATAGGCATTCATAAACAATC             
  PIV1 N gene                   PIV1NF       64--89 bp primer location was relative to NC003461, Washington 1964 strain (Osiowy C 1998)                     TCTGGCGGAGGAGCAATTATACCTGG          84 bp
                                PIV1NR       122--147 bp primer location was relative to NC003461, Washington 1964 strain (Osiowy C 1998)                   ATCTGCATCATCTGTCACACTCGGGC          
  PIV2 N gene                   PIV2NF       221--242 bp primer location was relative to AF533012, Greer strain                                             GATGACACTCCAGTACCTCTTG              197 bp
                                PIV2NR       395--416 bp primer location was relative to AF533012, Greer strain                                             GATTACTCATAGCTGCAGAAGG              
  PIV3 N gene                   PIV3NF       439--465 bp primer location was relative to D10025 strain                                                      GATCCACTGTGTCACCGCTCAATACC          266 bp
                                PIV3NR       680--705 bp primer location was relative to D10025 strain                                                      CTGAGTGGATATTTGGAAGTGACCTGG         
  hMPV N gene                   hMPVNF       79--104 bp primer location was relative to hMPV 00--1 (AF371337) strain (Banerjee *et al*., 2007)              AAGCATGCTATATTAAAAGAGTCTCA          440 bp
                                hMPVNR       496--518 bp primer location was relative to hMPV 00--1 (AF371337) strain (Banerjee *et al*., 2007)             ATTATGGGTGTGTCTGGTGCTGA             
  RSV N gene (nested primers)   RSVAF        156--180 bp primer location was relative to RSV A (U39961) strains                                             AAGCAAATGGAGTGGATGTAACAAC           260 bp
                                RSVAR        532--554 bp primer location was relative to RSV A (U39961) strains                                             CTCCTAATCACAGCTGTAAGACCCA           
                                RSVBF        135--160 bp primer location was relative to RSV B (AF013254) strain                                            CAAACTATGTGGTATGCTATTAATCA          328 bp
                                RSVBR        463--486 bp primer location was relative to RSV B (AF013254) strain                                            ACACAGTATTATCATCCCACAGTC            
  Influenza A matrix gene       Inf AF       119--140 bp primer location was relative to NC003150 (A/New Caledonia/20/99) and NC032261 (A/Panama/2007/99)   AGGYWCTYATGGARTGGCTAAAG             105 bp
                                Inf AR       204--223 bp primer location was relative to NC003150 (A/New Caledonia/20/99) and NC032261 (A/Panama/2007/99)   GCAGTCCYCGCTCASTGGGC                
  Influenza B matrix gene       Inf BF       54--76 bp primer location was relative to CY018638 strain                                                      GGAGAAGGCAAAGCAGAACTAGC             503 bp
                                Inf BR       531--554 bp primer location was relative to CY018638 strain                                                    CCATTCCATTCATTGTTTTTGCTG            
  GAPDH primers                 GAPDH1       Gueudin *et al*., 2003                                                                                         TCA TCC ATG ACAACT TTG GTA TCG TG   564 bp
                                GAPDH1       Gueudin *et al*., 2003                                                                                         CTC TTC CTC TTG TGCTCT TG           

Y, W, R, S are wobbles for C/T, A/T, A/G and G/C

PCR standardization
-------------------

cDNA was synthesized from pooled RNA of different viruses to generate template for multiplex PCR. Parameters that were optimized included different concentrations of primers, dNTPs, magnesium chloride (MgCl~2~), Taq polymerase, adjuvants (DMSO and glycerol) and cycling conditions for a 25 μl reaction. If RSV was detected then nested PCR was done for typing of RSV into group A or B. All the PCR reactions were conventional block PCR assays, carried out in GeneAmp^®^PCR System 9700 (Applied Biosystems, USA) using plasticware from Axygen Scientific, USA.

An internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was included to check the presence of inhibitors of the RT-PCR assay.

Sensitivity and specificity of the Multiplex PCR
------------------------------------------------

The sensitivity of the multiplex PCR assay was determined by TCID~50~using Reed and Muench method \[[@B43]\]. Inter and intra assay specificity of the primers was tested with RNA extracted from RSV A and B, PIV1--3, Influenza A and B viruses, hMPV, enteroviruses, cytomegalovirus, herpes simplex virus 1 & 2.

Virus isolation by centrifugation enhanced culture
--------------------------------------------------

Virus isolations were done using centrifugation enhanced culture (CEC) followed by indirect immunofluorescence (IIF) as described previously \[[@B35]\].

Costing methods
---------------

Costs are reported in this manuscript using United States dollar values, with 2006 taken as the reference year for reporting unit prices.

Metrological data
-----------------

The environmental factors namely rainfall (cm), temperature (°C) and humidity (RH in %) were acquired from the India Meteorological Department, Regional Meteorological Centre, New Delhi, India.

Statistical analysis
--------------------

Statistical analysis was carried out using STATA 9.0 (College station, Texas, USA). Data were presented as number or median (Range). Validity of multiplex PCR in comparison to CEC-IIF was assessed using sensitivity (95% CI), specificity (95% CI) and likelihood ratio. The association between clinical features at the time of presentation and virus detection was tested using Chi-square/Fisher\'s exact test as appropriate and OR (95% CI) was also calculated. A p value of \< 0.05 was considered statistically significant.
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